Elizabeth Romer: Changing the way we talk about people who use drugs is a step towards challenging stigma

In a recent BMJ Opinion article, Ian Hamilton expressed his scepticism that “adopting a new vocabulary to describe people who have problems with drugs will reduce the stigma they experience.” I agree that language alone cannot reduce this kind of stigma or prejudice, but it’s a good place to start. As a final year medical […]

Read More…

Jeffrey Aronson: When I Use a Word . . . The wheel of evidence

Last week I discussed the concept of teleoanalysis, in which different types of evidence from disparate sources are analysed either simultaneously or sequentially. To be clear, the term implies not the very last analysis that could be done, but a thorough systematic analysis of all the evidence available at the time, from, for example, randomised […]

Read More…

Laurie Tomlinson: From patient to data and back again—how anonymised patient records can improve prescribing guidance

We often hear about the importance of “bench to bedside” medicine, how basic science research is translated into novel treatments. But this paper demonstrates an equally important concept: how anonymised health records provide a rich data source to address clinical questions, which in turn improves patient care. I work as a clinical academic, undertaking outpatient […]

Read More…